Telescope Innovations increases financing to $6.5M

Mr. Henry Dubina reports TELESCOPE UPSIZES PRIVATE PLACEMENT Telescope Innovations Corp., due to strong demand, has increased the size of its previously announced non-brokered private placement under the listed issuer financing exemption (LIFE) (as defined below) to up to 26 million common shares of the company at a price of 25 cents per common share, to raise gross proceeds of up to $6.5-million. The net proceeds raised from the offering will be used to improve inventory position to ensure consistent customer deliveries and infrastructure, and for general working capital purposes. In addition, the proceeds will enable the company to speed development of the self-driving laboratory (SDL) project and increase business development capacity. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, Prospectus Exemptions, the offering is being made to purchasers' resident in Canada, except Quebec, as well as certain jurisdictions outside of Canada, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106. For more information regarding the offering, readers are encouraged to review the company's news releases issued on July 29, 2025, and July 3, 2025, and the amended and restated offering document filed by the company, a copy of which is accessible under the company's profile on SEDAR+ and on the corporate website. About Telescope Innovations Corp. Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The company builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency and data quality. The company's aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability. We seek Safe Harbor.